Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

1,3-dipropyl-8-cyclopentylxanthine has been researched along with 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Sarro, A; De Sarro, G; Donato Di Paola, E; Falconi, U; Ferreri, G	1

Other Studies

1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

Article	Year
Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene. European journal of pharmacology, 1996, Dec-19, Volume: 317, Issue:2-3 Topics: Acoustic Stimulation; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticonvulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Mice; Mice, Inbred DBA; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Triazoles; Xanthines	1996

Article

Year

Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.

European journal of pharmacology, 1996, Dec-19, Volume: 317, Issue:2-3

Topics: Acoustic Stimulation; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticonvulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Mice; Mice, Inbred DBA; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Triazoles; Xanthines

1996